WASHINGTON, Aug. 21 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Everlaan Organics Inc. dba Maple Organics from Center for Drug Evaluation and Research: * * * Recipient: Ms. Rosy Atwal, Founder and CEO, Everlaan Organics, Inc. dba Maple Organics, 17220 Heather Dr, Unit 106, Surrey BC V3S 8G6, Canada Issuing Office: Center for Drug Evaluation and Research (CDER), United States Warning Letter 320-25-99 Dear Ms. Atwal:   more